Neural Implants Market to Grow at a CAGR of 9.7% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Neural Implants Market?

The market for neural implants has seen robust expansion lately, projected to move from a valuation of $5.39 billion in 2024 to $5.91 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.8%. This expansion throughout the historical timeframe stems from several key factors, including the proliferation of highly reputable healthcare centers, an expanding elderly demographic, an increasing inclination towards surgical methods that involve smaller incisions, rising consumer desire for treatments tailored to individual needs, and the enhanced presence of better medical infrastructure.

Anticipating vigorous expansion, the market for neural implants is projected to reach a valuation of $8.56 billion by the year 2029, achieving a compound annual growth rate of 9.7% over this period. This upward trajectory is fundamentally driven by several factors, including the increasing incidence of various neurological conditions, greater patient recognition regarding novel therapeutic approaches for these disorders, the broader accessibility of efficacious devices, a marked preference forming for brain implants that are safely compatible with MRI technology, and the augmented deployment of high-frequency neuromodulation treatments. Key developments set to influence this market during the said timeframe encompass continuous product breakthroughs, significant technological evolutions, progress within the field of neuroprosthetics, and the incorporation of deep learning methods into neural implant systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15618&type=smp

Which Drivers Are Supporting Growth Of The Neural Implants Market?

The escalating incidence of conditions affecting the nervous system, which encompass any ailment of the brain, spinal cord, or peripheral nerves characterized by structural, biochemical, or electrical irregularities, is anticipated to be a key driver for the expansion of the neural implants industry. This upward trend in neurological ailments stems from factors like an aging global demographic, inherited tendencies, and modifications in how these conditions are identified. Neural implant technology facilitates the management and treatment of diverse neurological pathologies through direct interaction with the nervous system, aiming to either recover or boost impaired neural functions. This customized method holds the potential to enhance therapeutic outcomes and mitigate unwanted side effects, notably in conditions like epilepsy, Parkinson’s disease, and spinal cord damage. To illustrate this impact, the Alzheimer’s Association reported in March 2022 that close to seven million Americans aged 65 and above were living with Alzheimer’s dementia, a figure projected to nearly double to 13.8 million by the year 2060; furthermore, associated healthcare and extended care expenses for individuals afflicted with dementia are estimated to hit $360 billion in 2024, potentially escalating to around $1 trillion by 2050, underscoring why the increasing frequency of neurological disorders fuels the progress of the neural implants market.

How Is The Neural Implants Market Classified Into Different Segments?

The neural implantsmarket covered in this report is segmented –

1) By Product: F And B Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS)

2) By Application: Chronic Pain, Parkinson’s Disease (PD), Epilepsy, Other Applications

3) By End-User: Hospitals, Specialized Neurological Centers (SNCs), Outpatient Surgery Centers

Subsegments:

1) By F And B Spinal Cord Stimulation (Scs): Traditional Spinal Cord Stimulation, High-Frequency Spinal Cord Stimulation, Burst Spinal Cord Stimulation

2) By Deep Brain Stimulation (Dbs): Subthalamic Nucleus (Stn) Dbs, Globus Pallidus Internus (Gpi) Dbs, Ventral Intermediate Nucleus (Vim) Dbs

3) By Vagus Nerve Stimulation (Vns): Implantable Vagus Nerve Stimulators, Non-Invasive Vagus Nerve Stimulators

What Trends Are Expected To Drive The Neural Implants Market?

Key players within the neural implant sector are concentrating their efforts on engineering novel solutions, specifically deep brain stimulation (DBS) systems, with the primary aim of addressing motility impairments like Parkinson’s disease and essential tremors, thereby securing a favorable position in the marketplace. DBS apparatuses constitute medical implants engineered to manage central nervous system conditions by transmitting electrical signals to predetermined brain regions. As an illustration, in the initial month of 2024, Abbott Laboratories, a prominent US healthcare and medical device firm, introduced Liberta RC, recognized globally as the most compact, remotely programmable, rechargeable DBS instrument designed for individuals suffering from movement disorders. This particular technology boasts the lowest frequency of required recharging among all FDA-cleared DBS platforms, necessitating mere adjustments ten times annually for the majority of recipients. Furthermore, this offering integrates seamlessly with Abbott’s proprietary NeuroSphere virtual environment, facilitating remote connectivity between patients and their healthcare providers, confirmation of device operation and correct configuration, alongside the reception of refined treatment parameters without a physical visit. The unit utilizes an inductive charging mechanism that is simply placed over the implanted component, enabling continued daily activities while the patient is wearing it, and it furnishes users with relevant alerts and tailored configurations to guarantee a charging routine customized to individual needs.

Which Industry Leaders Are Driving Innovation Across The Neural Implants Market?

Major companies operating in the neural implants market are Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Smith & Nephew plc, Integra LifeSciences, Cochlear Ltd., LivaNova PLC, Renishaw plc, MicroPort Scientific Corporation, Nevro Corp., Inspire Medical Systems Inc., Cyberonics Inc., Axonics Modulation Technologies Inc., Saluda Medical, NeuroPace Inc., Fisher Wallace, BioControl Medical, Cerbomed GmbH, Nuvectra Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/neural-implants-global-market-report

Which Regional Markets Are Contributing Most To The Neural Implants Industry Expansion?

North America was the largest region in the neural implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neural implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Neural Implants Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15618&type=smp

Browse Through More Reports Similar to the Global Neural Implants Market 2025, By The Business Research Company

Cranial Implants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cranial-implants-global-market-report

Orthopedic Biomaterials Market 2025

https://www.thebusinessresearchcompany.com/report/orthopedic-biomaterials-market

Dental Implants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dental-implants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795